Companies
Employees11-50
FundingOver $10M
2 active roles
Healthcare AIAI ApplicationAPI / PlatformSeed$10M-$50M
About
Graph Therapeutics builds an AI-powered lab-in-the-loop platform for precision drug discovery in inflammation and immunology. They target pharmaceutical companies and biotech researchers by combining primary patient cell perturbation modeling with multi-omics data to identify high-impact drug targets. The company generates value by developing an internal precision therapeutics pipeline to treat immune-driven diseases.
Active Roles
2Key Investors
Daphni, SquareOne, Merantix Capital, NAVEC Investment Management